MAPS

MAPS PBC Medical Advisor Believes Cannabis Is A Type Of Psychedelic

Apr 6, 2023

MAPS PBC Announces Positive Topline Results From MDMA Assisted Therapy Observational Study

Apr 5, 2023

Ambria Capital Managing Partner Sees Better Times Ahead In The Psychedelic Sector

Mar 31, 2023

MAPS Executive Director Predicts MDMA Assisted Therapy Will Be Approved “Sometime Around April-May 2024”

Jan 27, 2023

Potential For MDMA Assisted Therapy Approval Boosts Psychedelic Stocks Early In 2023

Jan 10, 2023

MAPS Clinical Trial Shows Follow-Up Positive Results For MDMA-Assisted Therapy

Jan 6, 2023

TDR’s Top 5 Psychedelic Developments For The Week Of November 14

Nov 19, 2022

MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD

Nov 18, 2022

Trade To Black Podcast: Numinus CEO Breaks Down B.C. Drug Possession News And Macro Psychedelic Market

Jun 5, 2022

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Apr 12, 2022